OncoPrecision
PrivateLast Round
Seed
Apr 1, 2022
Total Funding Raised
$4.15M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
OncoPrecision operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in April 2022.
OncoPrecision is a biotechnology company that develops precision oncology therapeutics and patient-derived micro-avatar platforms to tailor cancer therapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoPrecision Comparables
Compare OncoPrecision with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Solu Therapeutics | 84% | |
| AmMax Bio Inc. | 79% | |
| Dren Bio | 77% |
For institutional investors. Book with your work email.
OncoPrecision Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 1, 2022 | ||||
| Pre Seed | Feb 16, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
OncoPrecision Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Creative Ventures | Seed |
| GRIDX | Seed, Pre Seed |
| IndieBio | Pre Seed |
| New York Ventures | Seed |
| SOSV | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 89% MoM.
- Dec 1, 2025
Will attend and present at the 67th ASH Annual Meeting.
For institutional investors. Book with your work email.
OncoPrecision Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OncoPrecision's valuation, stock price, and market status.
Is OncoPrecision a public or private company?
OncoPrecision is a private company.
What is the current stock price of OncoPrecision?
OncoPrecision is a private company, so its shares have no public market price. Caplight tracks OncoPrecision's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OncoPrecision worth (valuation)?
Valuation information for OncoPrecision is not publicly available.
Can I buy OncoPrecision stock?
OncoPrecision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OncoPrecision's last funding round?
OncoPrecision's most recent funding round was Seed on April 1, 2022.
Who are the main investors in OncoPrecision?
Key investors in OncoPrecision include GRIDX.
Will OncoPrecision IPO soon?
No public IPO plans have been announced for OncoPrecision.
How can I track OncoPrecision secondary market activity?
Caplight tracks bids, offers, and trades in OncoPrecision's shares on secondary markets.